FibroGen (FGEN) – Analyst Ratings
-
BofA Securities Downgrades FibroGen (FGEN) to Underperform, 'unfavorable catalyst pathway'
-
Stifel Downgrades FibroGen (FGEN) to Hold
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to FGEN Stock Lookup